These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 5577479)
1. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Introduction. McDowell F Clin Pharmacol Ther; 1971; 12(2):317-8. PubMed ID: 5577479 [No Abstract] [Full Text] [Related]
2. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Where do we go from here? Clin Pharmacol Ther; 1971; 12(2):408-16. PubMed ID: 5577487 [No Abstract] [Full Text] [Related]
3. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Clinical laboratory abnormalities. McDowell F Clin Pharmacol Ther; 1971; 12(2):335-9. PubMed ID: 4102803 [No Abstract] [Full Text] [Related]
4. [Clinical results with levodopa in Parkinson's disease]. Crudeli R Sist Nerv; 1970; 22(2):124-5. PubMed ID: 5504551 [No Abstract] [Full Text] [Related]
5. [Levodopa and Parkinson's disease]. Rinne UK Duodecim; 1971; 87(12):929-32. PubMed ID: 5088231 [No Abstract] [Full Text] [Related]
7. [Treatment of Parkinson's syndrome with levodopa]. Rossi CA Prensa Med Argent; 1970 Oct; 57(31):1516-8. PubMed ID: 5485492 [No Abstract] [Full Text] [Related]
8. [Drug therapy of Parkinson's disease with amantadine and levodopa]. Fieschi C; Nardini M; Casacchia M; Reitano M; Tedone ME; Ferrari P; Robotti E Sist Nerv; 1970; 22(2):126-43. PubMed ID: 5504552 [No Abstract] [Full Text] [Related]
9. [Electrophysiological effect of Levodopa on the phenomena of spinal inhibition and facilitation in Parkinson's disease]. Cernibori Riv Neurol; 1970; 40(5):303-9. PubMed ID: 5503723 [No Abstract] [Full Text] [Related]
10. [The therapeutic use of L-DOPA in Parkinson's disease. Biochemical, pharmacological and clinical considerations]. Morselli PL; Rizzo M; Tognoni G Recenti Prog Med; 1970 Feb; 48(2):97-124. PubMed ID: 5467589 [No Abstract] [Full Text] [Related]
11. [Results of treatment with levodopa and rehabilitative therapy in 10 cases of Parkinson's disease]. Paciaroni E; Raspa EG Sist Nerv; 1970; 22(2):153-61. PubMed ID: 5504554 [No Abstract] [Full Text] [Related]
12. Levodopa and physical therapy in treatment of patients with Parkinson's disease. Stern PH; McDowell F; Miller JM; Robinson M Arch Phys Med Rehabil; 1970 May; 51(5):273-7. PubMed ID: 5420013 [No Abstract] [Full Text] [Related]
13. [Etiology and therapy of Parkinson's syndrome and related pharmacological concepts shown in experimental models]. Oehme P; Schwarz K Dtsch Gesundheitsw; 1966 Apr; 21(17):792-8. PubMed ID: 5929188 [No Abstract] [Full Text] [Related]
14. Pharmacodynamics of 3, 4-dihydroxyphenylalanine (Dopa) in Parkinson's disease. Van Woert MH Conn Med; 1970 Jun; 34(6):401-5. PubMed ID: 5431103 [No Abstract] [Full Text] [Related]
15. L-dopa in Parkinson's disease. Cleghorn RA Can Med Assoc J; 1970 Jun; 102(13):1410 passim. PubMed ID: 5422440 [No Abstract] [Full Text] [Related]
16. [Parkinson's disease and its current treatment]. Sigwald J Cah Med; 1971 Jun; 12(10):859-67. PubMed ID: 5112591 [No Abstract] [Full Text] [Related]
17. [L-dopa in the treatment of Parkinson's disease]. Völler G Med Welt; 1970 Jul; 27():1267-8. PubMed ID: 5512643 [No Abstract] [Full Text] [Related]
18. [Treatment of Parkinson's disease by L-DOPA]. Barbeau A Union Med Can; 1969 Feb; 98(2):183-6. PubMed ID: 5773394 [No Abstract] [Full Text] [Related]
19. Progress in the treatment of Parkinson's disease. Kelly R J R Nav Med Serv; 1969; 55(1):26-34. PubMed ID: 5775493 [No Abstract] [Full Text] [Related]
20. Management of Parkinson's disease with L-dopa therapy. Tyler E Can Nurse; 1971 Apr; 67(4):41-2. PubMed ID: 5549360 [No Abstract] [Full Text] [Related] [Next] [New Search]